Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Structurally-modified antibody – immunoglobulin – or fragment...
Reexamination Certificate
2007-12-14
2008-11-11
Saoud, Christine J (Department: 1647)
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Structurally-modified antibody, immunoglobulin, or fragment...
C424S192100, C514S002600, C514S012200, C530S350000, C536S023400
Reexamination Certificate
active
07449182
ABSTRACT:
Disclosed are compositions and methods for treating a disease or condition related to angiogenesis with a vascular endothelial growth factor (VEGF) inhibitor and one or more anti-hypertensive agent(s). The method of the invention is useful for preventing the development of hypertension and/or reducing hypertension in a subject treated with a VEGF inhibitor.
REFERENCES:
patent: 6897294 (2005-05-01), Davis-Smyth et al.
patent: 2003/0144298 (2003-07-01), Curwen et al.
patent: WO 2004/110490 (2004-12-01), None
patent: WO 2005/000895 (2005-01-01), None
Cedarbaum Jesse M.
Holash Jocelyn
Gregg, Esq. Valeta
Lockard Jon M
Regeneron Pharmaceuticals Inc.
Saoud Christine J
LandOfFree
Therapeutic combination of a VEGF antagonist and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Therapeutic combination of a VEGF antagonist and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Therapeutic combination of a VEGF antagonist and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4028999